WELL Health Technologies Corp.
WHTCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $262 | $357 | $294 | $193 |
| % Growth | -26.6% | 21.3% | 52.2% | – |
| Cost of Goods Sold | $162 | $198 | $177 | $152 |
| Gross Profit | $100 | $159 | $117 | $41 |
| % Margin | 38.2% | 44.5% | 39.9% | 21.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $84 | $67 | $62 |
| SG&A Expenses | $76 | $107 | $90 | $85 |
| Sales & Mktg Exp. | $0 | $23 | $24 | $22 |
| Other Operating Expenses | $0 | $24 | $20 | $20 |
| Operating Expenses | $76 | $132 | $110 | $105 |
| Operating Income | $24 | $27 | $8 | -$64 |
| % Margin | 9.1% | 7.6% | 2.6% | -33.1% |
| Other Income/Exp. Net | -$19 | -$4 | -$51 | $13 |
| Pre-Tax Income | $5 | $23 | -$43 | -$51 |
| Tax Expense | $7 | $6 | -$1 | -$19 |
| Net Income | $3 | $12 | -$47 | -$13 |
| % Margin | 1.1% | 3.4% | -15.8% | -6.7% |
| EPS | 0.012 | 0.048 | -0.19 | -0.053 |
| % Growth | -75.4% | 125.3% | -258.5% | – |
| EPS Diluted | 0.012 | 0.048 | -0.19 | -0.051 |
| Weighted Avg Shares Out | 254 | 253 | 250 | 247 |
| Weighted Avg Shares Out Dil | 257 | 253 | 250 | 255 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $13 | $9 | $11 | $9 |
| Depreciation & Amortization | $19 | $25 | $20 | $21 |
| EBITDA | $37 | $61 | -$13 | -$21 |
| % Margin | 14.1% | 17.1% | -4.3% | -11% |